These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35352023)

  • 1. miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma.
    El Bezawy R; Percio S; Ciniselli CM; De Cesare M; Colella G; Dugo M; Veneroni S; Doldi V; Martini S; Baratti D; Kusamura S; Verderio P; Deraco M; Gandellini P; Zaffaroni N; Zuco V
    Cancer Gene Ther; 2022 Oct; 29(10):1394-1404. PubMed ID: 35352023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.
    El Bezawy R; De Cesare M; Pennati M; Deraco M; Gandellini P; Zuco V; Zaffaroni N
    J Hematol Oncol; 2017 Jan; 10(1):19. PubMed ID: 28100259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells.
    Cimino-Reale G; Gandellini P; Santambrogio F; Recagni M; Zaffaroni N; Folini M
    J Hematol Oncol; 2017 Jul; 10(1):140. PubMed ID: 28716051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2.
    Ho JY; Hsu RJ; Wu CH; Liao GS; Gao HW; Wang TH; Yu CP
    Oncotarget; 2016 Aug; 7(33):53853-53868. PubMed ID: 27462780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-550a-3p promotes non-small cell lung cancer cell proliferation and metastasis through down-regulating TIMP2.
    Yang JZ; Bian L; Hou JG; Wang HY
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4156-4165. PubMed ID: 30024604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma.
    Belfiore A; Busico A; Bozzi F; Brich S; Dallera E; Conca E; Capone I; Gloghini A; Volpi CC; Cabras AD; Pilotti S; Baratti D; Guaglio M; Deraco M; Kusamura S; Perrone F
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
    Li Y; Wu C
    IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.
    Choe MH; Yoon Y; Kim J; Hwang SG; Han YH; Kim JS
    Cell Death Dis; 2018 May; 9(6):640. PubMed ID: 29844307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.
    Sciarrillo R; Wojtuszkiewicz A; El Hassouni B; Funel N; Gandellini P; Lagerweij T; Buonamici S; Blijlevens M; Zeeuw van der Laan EA; Zaffaroni N; Deraco M; Kusamura S; Würdinger T; Peters GJ; Molthoff CFM; Jansen G; Kaspers GJL; Cloos J; Giovannetti E
    EBioMedicine; 2019 Jan; 39():215-225. PubMed ID: 30581150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCNQ1OT1 facilitates progression of non-small-cell lung carcinoma via modulating miRNA-27b-3p/HSP90AA1 axis.
    Dong Z; Yang P; Qiu X; Liang S; Guan B; Yang H; Li F; Sun L; Liu H; Zou G; Zhao K
    J Cell Physiol; 2019 Jul; 234(7):11304-11314. PubMed ID: 30471108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mir-421 and mir-550a-1 are potential prognostic markers in esophageal adenocarcinoma.
    Ji Y; Wang L; Chang G; Yan J; Dai L; Ji Z; Liu J; He M; Xu H; Zhang L
    Biol Direct; 2023 Feb; 18(1):5. PubMed ID: 36829221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV.
    Endo I; Amatya VJ; Kushitani K; Nakagiri T; Aoe K; Takeshima Y
    Pathobiology; 2023; 90(4):270-280. PubMed ID: 36724751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma.
    Oliveto S; Alfieri R; Miluzio A; Scagliola A; Secli RS; Gasparini P; Grosso S; Cascione L; Mutti L; Biffo S
    Cancer Res; 2018 Oct; 78(20):5741-5753. PubMed ID: 30072395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSP90: A Novel Target Gene of miRNA-628-3p in A549 Cells.
    Pan J; Jiang F; Zhou J; Wu D; Sheng Z; Li M
    Biomed Res Int; 2018; 2018():4149707. PubMed ID: 29888262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.
    De Cesare M; Cominetti D; Doldi V; Lopergolo A; Deraco M; Gandellini P; Friedlander S; Landesman Y; Kauffman MG; Shacham S; Pennati M; Zaffaroni N
    Oncotarget; 2015 May; 6(15):13119-32. PubMed ID: 25948791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt/β-catenin signaling pathway.
    Li CM; Wu W; Zhu Z; Lu PL; Gong JP; Ma R
    Neoplasma; 2022 Dec; 69(6):1359-1372. PubMed ID: 36353937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-550a-3p restores damaged vascular smooth muscle cells by inhibiting thrombomodulin in an in vitro atherosclerosis model.
    Chen S; Zhang L; Feng B; Wang W; Liu D; Zhao X; Yu C; Wang X; Gao Y
    Eur J Histochem; 2022 Jul; 66(3):. PubMed ID: 35855629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.
    Williams M; Kirschner MB; Cheng YY; Hanh J; Weiss J; Mugridge N; Wright CM; Linton A; Kao SC; Edelman JJ; Vallely MP; McCaughan BC; Cooper W; Klebe S; Lin RC; Brahmbhatt H; MacDiarmid J; van Zandwijk N; Reid G
    Oncotarget; 2015 Sep; 6(27):23480-95. PubMed ID: 26125439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.
    De Cesare M; Sfondrini L; Pennati M; De Marco C; Motta V; Tagliabue E; Deraco M; Balsari A; Zaffaroni N
    J Transl Med; 2016 Jan; 14():25. PubMed ID: 26810896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.